Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	285.71	-283.34	73.46
Graham Fair Price	-8.61	68.17	74.59
PEG	-61.41	-0.24	0.63
Price/Book	-2.19	0.41	0.41
Price/Cash Flow	0.87	-4.06	-4.10
Prices/Earnings	13.43	3.35	2.95
Price/Sales	1.16	3.72	3.68
Price/FCF	0.87	-4.06	-4.10
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	20.77	0.37	0.31
ROA	-13.38	< 0.005	< 0.005
ROE	0.04	0.03	-13.77
ROIC	< 0.005	0.02	102.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.68	< 0.005	13741.78
Dividends QOQ	-0.01	< 0.005	-33.82
EBIT QOQ	-0.12	0.16	27.79
EPS QOQ	0.05	-0.14	193.90
FCF QOQ	-2.40	0.02	-99.00
Revenue QOQ	-0.08	-0.04	46.95
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	202.90	0.00	inf
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.79	0.55	-30.56
Quick Ratio	1.82	0.00	inf
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	83.95	82.62	-1.58
Cash	151.26	50.64	-66.52
Capex	-0.55	-0.34	37.56
Free Cash Flow	-8.48	-8.24	2.89
Revenue	9.45	8.99	-4.84
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.82	0.00	inf
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	63.37	-168.86	166.47
Naive Interpretation	Member

06 - Financial Health · Bad

Rating